Literature DB >> 15664248

Multistep and multicentric development of hepatocellular carcinoma: histological analysis of 980 resected nodules.

Takuichi Oikawa1, Hidenori Ojima, Susumu Yamasaki, Tadatoshi Takayama, Setsuo Hirohashi, Michiie Sakamoto.   

Abstract

BACKGROUND/AIMS: Histological observations support the concept of multistep and multicentric development of hepatocellular carcinoma (HCC) in cases of chronic liver disease. However, the relationship between the incidence of such a modality of development of HCC and the type of background liver disease has not been fully investigated.
METHODS: A total of 980 HCC nodules resected from 664 patients were analyzed. Multistep HCC was defined as well differentiated HCC containing the portal tracts (early HCC), or the presence of early HCC-like areas in the periphery of the nodule. In cases with multiple nodules, if the smaller nodule showed the features of multistep HCC, or if each nodule showed a distinct histology, the case was defined to have multicentric HCC.
RESULTS: Of the 980 nodules, 369 (37.7%) met the criteria of multistep HCC. Of the 664 patients, 177 (26.7%) had multiple nodules that met the criteria of multicentric HCC. Both the incidences of multistep and multicentric HCC were significantly higher in HCV-Ab-positive cases than in HBs-Ag-positive cases (46.0 vs. 19.1%, P<0.001 and 34.1 vs. 16.5%, P=0.005, respectively).
CONCLUSIONS: Multistep and multicentric HCC develops most frequently in patients with HCV infection.

Entities:  

Mesh:

Year:  2005        PMID: 15664248     DOI: 10.1016/j.jhep.2004.10.024

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  17 in total

1.  Current management of patients with hepatocellular carcinoma.

Authors:  Tatsuo Kanda; Sadahisa Ogasawara; Tetsuhiro Chiba; Yuki Haga; Masao Omata; Osamu Yokosuka
Journal:  World J Hepatol       Date:  2015-07-28

2.  Multiple carcinogenesis contributes to the heterogeneity of HCC.

Authors:  Qiang Gao; Xiao-Ying Wang; Jian Zhou; Jia Fan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-11-25       Impact factor: 46.802

3.  Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis.

Authors:  Wei Zhang; Tian-Qiang Song; Ti Zhang; Qiang Wu; DA-Lu Kong; Qiang Li; Hui-Chuan Sun
Journal:  Mol Clin Oncol       Date:  2014-08-12

4.  Significance of anatomic resection for early and advanced hepatocellular carcinoma.

Authors:  Yoji Kishi; Akio Saiura; Junji Yamamoto; Rintaro Koga; Makoto Seki; Ryo Morimura; Ryuji Yoshioka; Norihiro Kokudo; Toshiharu Yamaguchi
Journal:  Langenbecks Arch Surg       Date:  2011-09-09       Impact factor: 3.445

5.  Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis.

Authors:  Hirokazu Kawai; Minoru Nomoto; Takeshi Suda; Kenya Kamimura; Atsunori Tsuchiya; Yasushi Tamura; Masahiko Yano; Masaaki Takamura; Masato Igarashi; Toshifumi Wakai; Satoshi Yamagiwa; Yasunobu Matsuda; Shogo Ohkoshi; Isao Kurosaki; Yoshio Shirai; Masahiko Okada; Yutaka Aoyagi
Journal:  World J Hepatol       Date:  2011-01-27

Review 6.  Histopathology of hepatocellular carcinoma.

Authors:  Manuel Schlageter; Luigi Maria Terracciano; Salvatore D'Angelo; Paolo Sorrentino
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

7.  Pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma.

Authors:  Takashi Iwata; Noritoshi Nishiyama; Koshi Nagano; Nobuhiro Izumi; Shinjiro Mizuguchi; Ryuhei Morita; Takuma Tsukioka; Shoji Hanada; Kiyotoshi Inoue; Shoji Kubo; Shigekazu Takemura; Shigefumi Suehiro
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

8.  Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Noboru Maeda; Keigo Osuga; Koji Mikami; Hiroki Higashihara; Hiromitsu Onishi; Yasuhiro Nakaya; Mitsuaki Tatsumi; Masatoshi Hori; Tonsok Kim; Kaname Tomoda; Hironobu Nakamura
Journal:  Radiat Med       Date:  2008-05-29

9.  PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.

Authors:  Naoki Tanaka; Kyoji Moriya; Kendo Kiyosawa; Kazuhiko Koike; Frank J Gonzalez; Toshifumi Aoyama
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

10.  Does microvascular invasion in Barcelona Clinic Liver Cancer stage A multinodular hepatocellular carcinoma indicate early-stage behavior?

Authors:  Han Wang; Long-Hai Feng; You-Wen Qian; Zhen-Ying Cao; Meng-Chao Wu; Wen-Ming Cong
Journal:  Ann Transl Med       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.